![Barbara Levi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Levi
General Counsel bei
UBS GROUP AG
Vermögen: 5 Mio $ am 31.05.2026
Profil
Barbara Levi currently works at European General Counsel Association, as Director, UBS AG, as Group General Counsel from 2021, UBS Group AG, as Group General Counsel from 2021, and King's College London, as Member-Employees Board.
Ms. Levi also formerly worked at Rio Tinto Plc, as Group General Counsel from 2020 to 2021, Rio Tinto Ltd., as Chief Legal, Governance & Ethics Officer in 2021, Sandoz International GmbH, as Global General Counsel from 2016 to 2019, and Novartis Pharma AG, as Global Legal Head-Product Strategy from 2014 to 2019.
Ms. Levi received her graduate degree from the University of Milan and graduate degree from Fordham University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UBS GROUP AG 0 % | 31.12.2024 | 99.876 ( 0 % ) | 5 Mio $ | 31.05.2026 |
Aktive Positionen von Barbara Levi
| Unternehmen | Position | Beginn |
|---|---|---|
| UBS GROUP AG | General Counsel | 01.11.2021 |
| UBS | General Counsel | 01.11.2021 |
European General Counsel Association | Direktor/Vorstandsmitglied | - |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Barbara Levi
| Unternehmen | Position | Ende |
|---|---|---|
| RIO TINTO PLC | Public Communications Contact | 25.10.2021 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | General Counsel | 01.01.2019 |
| RIO TINTO GROUP | Public Communications Contact | - |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | General Counsel | 01.01.2013 |
Ausbildung von Barbara Levi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Rio Tinto Plc
 Rio Tinto Plc Other Metals/MineralsNon-Energy Minerals Explores and mines for mineral resources | Non-Energy Minerals |
UBS AG
 UBS AG Investment ManagersFinance Provides financial advice and wealth management services | Finance |
UBS Group AG
 UBS Group AG Investment ManagersFinance Provides private wealth management, advisory, investment and corporate banking & asset management services | Finance |
Rio Tinto Ltd.
 Rio Tinto Ltd. Other Metals/MineralsNon-Energy Minerals Explores and mines for mineral resources | Non-Energy Minerals |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Fordham University School of Law
 Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European General Counsel Association |
